Device Trial Radar · NCT02305420
EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage
Last checked: Nov 19, 2026Latest source record: Feb 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Nov 2014
Primary completion
Jun 2017
Study completion Jun 14, 2017
Sponsor
- Lead sponsor
- FertilitySANot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Adelaide
- First posted
- Dec 2, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 25 years, up to 41 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EmbryoGen and BlastGen contain the cytokine growth factor Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), which has been documented to give significant benefit to this difficult group of patients. Results showed a highly significant effect of 44% relative improvement in ongoing implantation rate (p=0.001) in women who have previously miscarried (Ziebe et al 2013). We wish to undertake a randomised Controlled trial to determine if EmbryoGen/BlastGen media improves pregnancy outcomes in women with recurrent implantation failure, recurrent miscarriage and poor embryo development when compared to standard media.
Conditions
- Recurrent Miscarriage
- Infertility
Interventions
EmbryoGen/ BlastGen mediaDevice
Embryos will be cultured in media containing Gm-CSF (EmbryoGen/ BlastGen media)
Standard Cook sequential mediaDevice
Standard Cook IVF media will be used in the control arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Livebirth >20 weeksTime frame: 9 months after closure of trial (18 +9 months)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
FertilitySA
Adelaide, South Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.